US Broker Ratings

Veracyte, Inc. (VCYT) Stock Report: Analyst Ratings Highlight a Promising 9.12% Upside

Veracyte, Inc. (NASDAQ: VCYT) stands out in the healthcare sector, particularly within the diagnostics and research industry, with its innovative genomic diagnostic solutions. Headquartered in South..

LivaNova PLC (LIVN) Investor Outlook: Exploring a Promising 9.58% Potential Upside

LivaNova PLC (NASDAQ: LIVN), a key player in the medical devices industry, is drawing investor attention with its noteworthy potential upside of 9.58%. As a company..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a 63.55% Potential Upside in the Healthcare Sector

Perrigo Company plc (NYSE: PRGO), a prominent player in the healthcare sector, is capturing investor attention with a notable potential upside of 63.55%, as highlighted by..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Evaluating a 13.16% Potential Upside Amidst Market Challenges

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) stands as a significant player in the healthcare sector, specifically within the medical instruments and supplies industry. With a rich history..

Alvotech (ALVO) Stock Analysis: Unpacking a Potential 310% Upside in the Biosimilar Market

Alvotech (NASDAQ: ALVO) is emerging as a dynamic player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Based in Luxembourg, the..

Soleno Therapeutics, Inc. (SLNO) Investor Outlook: Analyzing a Potential 118% Upside

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is making waves in the biotechnology sector with its focus on developing novel therapies for rare diseases. With a current market..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Exploring a 26.95% Upside Potential

Prestige Consumer Healthcare Inc. (NYSE: PBH) presents a compelling opportunity for investors seeking exposure in the healthcare sector, specifically within the drug manufacturing segment. With a..

Alkermes plc (ALKS): Investor Outlook Reveals 53% Potential Upside with Strong Buy Ratings

Alkermes plc (NASDAQ: ALKS), a prominent player in the biopharmaceutical sector, is drawing significant attention from investors, thanks to its robust product pipeline and impressive analyst..

RadNet, Inc. (RDNT) Stock Analysis: Exploring a 24% Potential Upside with Strong Buy Ratings

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector specializing in diagnostics and research, presents an intriguing opportunity for investors seeking growth in the..

TG Therapeutics, Inc. (TGTX): Investor Outlook and 41% Upside Potential

TG Therapeutics, Inc. (NASDAQ: TGTX) stands as a formidable player within the biotechnology sector, with a market capitalization of $4.98 billion. Specializing in the acquisition and..

Lantheus Holdings, Inc. (LNTH): Investor Outlook on a Promising 23.52% Potential Upside

Lantheus Holdings, Inc. (NASDAQ: LNTH) is capturing the attention of investors with its compelling market performance and promising growth potential. As a key player in the..

Rhythm Pharmaceuticals, Inc. (RYTM) Investor Outlook: Navigating a 20.33% Potential Upside Amidst Strong Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands as a compelling player in the biotechnology sector, particularly for investors eyeing potential upside in the healthcare industry. Based in..

BrightSpring Health Services (BTSG) Stock Analysis: Exploring a 12.39% Upside Amidst Robust Revenue Growth

BrightSpring Health Services, Inc. (BTSG), a key player in the healthcare sector, has captured investor attention with its significant revenue growth and a promising potential upside...

Bio-Techne Corp (TECH) Stock Analysis: Exploring a 19% Upside Potential

Bio-Techne Corporation (NASDAQ: TECH), a prominent player in the healthcare sector, has been making waves with its innovative contributions to the biotechnology industry. Headquartered in Minneapolis,..

Bausch + Lomb Corporation (BLCO) Stock Report: Analyzing the Eye Health Giant’s Growth Potential

Bausch + Lomb Corporation (NYSE: BLCO) stands as a stalwart in the healthcare sector, particularly within the medical instruments and supplies industry. With its headquarters in..

Elanco Animal Health (ELAN) Stock Analysis: A Strong Buy with 15.98% Upside Potential

Elanco Animal Health Incorporated (NYSE: ELAN), a leader in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing for animals, is capturing..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating the Biotech Landscape with a Focus on Rare Disease Treatments

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a prominent player in the biotechnology sector, continues to command investor attention with its focus on RNA-targeted therapeutics and gene therapies..

iRhythm Technologies (IRTC) Stock Analysis: A 30.66% Upside Beckons in the Rapidly Growing Medical Device Sector

iRhythm Technologies, Inc. (NASDAQ: IRTC) is making waves in the healthcare sector with its innovative approach to cardiac monitoring. Based in San Francisco, this digital healthcare..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring Its 434% Revenue Growth and Strategic Position in RNA Therapeutics

For investors seeking to delve into the promising yet volatile world of biotechnology, Avidity Biosciences, Inc. (NASDAQ: RNA) presents a compelling case. This San Diego-based biopharmaceutical..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unpacking a 13.33% Potential Upside in the Biotech Space

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a prominent player in the biotechnology sector, is capturing investor attention with its impressive market cap of $14.48 billion and robust..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds